Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Doximity (DOCS)

NYSE Health Care Health Care Technology S&P MidCap 400
$32.51
-0.67 (-2.02%)
Close of Nov 06, 2026 · end-of-day data
Source: Doximity's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue$116.39M$206.90M$343.55M$419.05M$475.42M$570.40M$644.86M
Cost of revenue$14.90M$31.20M$39.79M$53.49M$50.67M$55.87M$70.33M
Gross profit$101.49M$175.70M$303.76M$365.56M$424.75M$514.52M$574.54M
Research & development$32.44M$43.87M$62.35M$80.19M$81.98M$93.04M$130.70M
Operating income$22.16M$53.30M$113.54M$125.11M$163.88M$227.80M$214.92M
Pre-tax income$23.51M$57.77M$114.00M$133.16M$185.20M$263.57M$250.00M
Income tax-$6.22M$7.56M-$40.78M$20.34M$37.62M$40.39M$53.95M
Net income$29.74M$50.21M$154.78M$112.82M$147.58M$223.19M$196.05M
EBITDA$23.06M$57.01M$118.58M$135.39M$174.14M$238.46M$229.30M
EPS (basic)$0.16$0.29$0.82$0.58$0.78$1.19$1.05
EPS (diluted)$0.13$0.23$0.70$0.53$0.72$1.11$0.98
Diluted shares81.71M95.13M191.02M213.43M205.73M201.21M199.05M
Gross margin87.2%84.9%88.4%87.2%89.3%90.2%89.1%
Operating margin19.0%25.8%33.0%29.9%34.5%39.9%33.3%
Net margin25.5%24.3%45.1%26.9%31.0%39.1%30.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash & equivalents$48.43M$66.39M$112.81M$158.03M$96.78M$209.61M$219.18M
Receivables—$50.32M$81.07M$107.05M$101.33M$128.35M$144.78M
Total current assets—$209.40M$904.14M$975.45M$912.94M$1.09B$944.26M
Goodwill—$18.91M$18.91M$67.94M$67.94M$67.94M$84.97M
Total assets—$251.72M$991.36M$1.14B$1.08B$1.26B$1.12B
Total current liabilities—$102.04M$111.28M$139.51M$147.25M$156.26M$154.97M
Total liabilities—$103.52M$112.76M$170.77M$177.98M$181.68M$172.85M
Shareholders' equity$1.14M$66.74M$878.59M$966.12M$901.40M$1.08B$950.84M

Cash flow

fiscal years · USD
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow$26.20M$82.97M$126.58M$179.60M$184.10M$273.26M$326.46M
Capital expenditures$285.00K$245.00K$1.91M$1.70M$147.00K$0$0
Free cash flow$25.91M$82.73M$124.66M$177.90M$183.95M$273.26M$326.46M
Investing cash flow-$13.10M-$70.42M-$640.57M-$59.92M$31.19M-$29.30M$147.17M
Financing cash flow$1.72M$5.41M$560.41M-$74.46M-$276.52M-$131.14M-$464.06M
Share buybacks$0$2.02M$2.70M$85.32M$280.72M$120.29M$431.65M
Stock-based compensation$2.35M$7.25M$31.44M$47.83M$51.08M$72.39M$121.63M
Depreciation & amortization$900.00K$3.70M$5.04M$10.28M$10.27M$10.66M$14.38M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.